Steady-State Plasma Concentration Profile of Transdermal Rotigotine: An Integrated Analysis of Three, Open-Label, Randomized, Phase I Multiple Dose Studies

This publication has 17 references indexed in Scilit:

• Absorption, Disposition, Metabolic Fate, and Elimination of the Dopamine Agonist Rotigotine in Man: Administration by Intravenous Infusion or Transdermal Delivery
  Drug Metabolism and Disposition, 2009
• Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine
  British Journal of Clinical Pharmacology, 2009
• Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial
  The Lancet Neurology, 2008
• Efficacy of rotigotine transdermal system in severe restless legs syndrome: A randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe
  Sleep Medicine, 2008
• Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial
  The Lancet Neurology, 2007
• Continuous delivery of rotigotine decreases extracellular dopamine suggesting continuous receptor stimulation
  Journal of Neural Transmission, 2007
• Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease
  Neurology, 2007
• Transdermal Administration of Radiolabelled [14C]Rotigotine by a Patch Formulation
  Clinical Pharmacokinetics, 2007
• Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature
  Movement Disorders, 2001
• Continuous dopamine-receptor stimulation in early Parkinson's disease
  Trends in Neurosciences, 2000